Cargando…
COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic
Autor principal: | Al-Samkari, Hanny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930930/ https://www.ncbi.nlm.nih.gov/pubmed/36820404 http://dx.doi.org/10.1016/j.rpth.2023.100039 |
Ejemplares similares
-
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019) -
Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019) -
The role of romiplostim for pediatric patients with immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2020) -
Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice
por: Song, Fei, et al.
Publicado: (2021) -
Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features
por: Cheloff, Abraham Z., et al.
Publicado: (2020)